Check-Cap EPS - Earnings per Share 2014-2024 | CHEK
Check-Cap eps - earnings per share from 2014 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Check-Cap Annual EPS | |
|---|---|
| 2023 | $-3.00 |
| 2022 | $-3.37 |
| 2021 | $-4.14 |
| 2020 | $-9.20 |
| 2019 | $-34.60 |
| 2018 | $-52.20 |
| 2017 | $-134.40 |
| 2016 | $-140.94 |
| 2015 | $-254.50 |
| 2014 | $-283.31 |
| 2013 | $-785.11 |
| Check-Cap Quarterly EPS | |
|---|---|
| 2024-06-30 | $0.00 |
| 2023-12-31 | $-0.62 |
| 2023-09-30 | $-0.44 |
| 2023-06-30 | $-1.18 |
| 2023-03-31 | $-0.76 |
| 2022-12-31 | $-0.61 |
| 2022-09-30 | $-0.81 |
| 2022-06-30 | $-0.82 |
| 2022-03-31 | $-1.13 |
| 2021-12-31 | $-1.90 |
| 2021-09-30 | $-0.04 |
| 2021-06-30 | $-1.20 |
| 2021-03-31 | $-1.00 |
| 2020-12-31 | $1.80 |
| 2020-09-30 | $-1.80 |
| 2020-06-30 | $-2.40 |
| 2020-03-31 | $-6.80 |
| 2019-12-31 | $-9.20 |
| 2019-09-30 | $-8.40 |
| 2019-06-30 | $-8.20 |
| 2019-03-31 | $-8.80 |
| 2018-12-31 | $-2.80 |
| 2018-09-30 | $-10.00 |
| 2018-06-30 | $-14.00 |
| 2018-03-31 | $-25.40 |
| 2017-12-31 | $-27.60 |
| 2017-09-30 | $-27.60 |
| 2017-06-30 | $-40.40 |
| 2017-03-31 | $-38.80 |
| 2016-12-31 | $-28.09 |
| 2016-09-30 | $-26.41 |
| 2016-06-30 | $-36.01 |
| 2016-03-31 | $-50.42 |
| 2015-12-31 | $-52.82 |
| 2015-09-30 | $-55.22 |
| 2015-06-30 | $-43.22 |
| 2015-03-31 | $-124.85 |
| 2014-12-31 | $0.00 |
| 2013-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.004B | $0.000B |
| Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. | |||